Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.Zacks Premium also includes the Zacks Style Scores.What are the Zacks Style Scores?Developed ...

Dexcom, Inc. (NASDAQ:DXCM) Q3 2023 Earnings Conference Call October 26, 2023 4:30 PM ET Company Participants Sean Christensen - Director, Corporate Affairs & Head of IR Kevin Sayer - Executive Chairman, CEO & President Jereme Sylvain - EVP, CFO & CAO Jake Leach - EVP, Chief Operating Officer Terry Lauver - Chief Commercial Officer Conference Call Participants Robert Marcus - JPMorgan Chase & Co. Margaret Kaczor - William Blair & Company Larry Biegelsen - Wells Fargo Securities Danielle Antalffy - UBS Matt T ...

• • • • Three Months Ended September 30, Three Months Ended September 30, (In millions) 2023 2022 (In millions, except per share data) 2023 2022 GAAP gross profit $ 623.3 $ 494.2 GAAP net income $ 120.7 $ 101.2 Amortization of intangible assets (1) 7.1 — Amortization of intangible assets (1) 8.8 1.8 Non-GAAP gross profit $ 630.4 $ 494.2 Business transition and related costs (2) 1.1 1.6 Intellectual property litigation costs (3) 23.5 9.9 GAAP operating income $ 205.5 $ 147.5 Income from equity investments (4 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-51222 DEXCOM, INC. (Exact name of registrant as specified in its charter) Delaware 33-0857544 (State or other jurisdiction of incorporat ...

Dexcom, Inc. (NASDAQ:DXCM) Q2 2023 Earnings Conference Call July 27, 2023 4:30 PM ET Company Participants Sean Christensen - Director, Corporate Affairs & Head of IR Kevin Sayer - Executive Chairman, CEO & President Jereme Sylvain - EVP, CFO & CAO Jake Leach - EVP, Chief Operating Officer Conference Call Participants Danielle Antalffy - UBS Robert Marcus - JPMorgan Chase & Co. Jeffrey Johnson - Robert W. Baird & Co. Lawrence Biegelsen - Wells Fargo Securities Joanne Wuensch - Citigroup Matthew Miksic - Barc ...

• • • • Three Months Ended June 30, Three Months Ended June 30, (In millions) 2023 2022 (In millions, except per share data) 2023 2022 GAAP gross profit $ 546.4 $ 449.5 GAAP net income $ 115.9 $ 50.9 Amortization of intangible assets (1) 7.1 — Amortization of intangible assets (1) 8.8 1.9 Non-GAAP gross profit $ 553.5 $ 449.5 Business transition and related costs (2) 0.7 13.8 Intellectual property litigation costs (3) 20.8 9.2 GAAP operating income $ 128.1 $ 77.0 Adjustments related to taxes (4) (6.8) (6.3) ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-51222 DEXCOM, INC. (Exact name of registrant as specified in its charter) Delaware 33-0857544 (State or other jurisdiction of incorporation o ...

Dexcom, Inc. (NASDAQ:DXCM) Q1 2023 Earnings Conference Call April 27, 2023 4:30 PM ET Company Participants Sean Christensen - Director, Corporate Affairs & Head of IR Kevin Sayer - Executive Chairman, CEO & President Jereme Sylvain - EVP, CFO & CAO Conference Call Participants Robert Marcus - JPMorgan Chase & Co. Jeffrey Johnson - Robert W. Baird & Co. Lawrence Biegelsen - Wells Fargo Securities Cecilia Furlong - Morgan Stanley Danielle Antalffy - UBS Mathew Blackman - Stifel, Nicolaus & Company Margaret Ka ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-51222 DEXCOM, INC. (Exact name of registrant as specified in its charter) Delaware 33-0857544 (State or other jurisdiction of incorporation ...

DexCom, Inc. (NASDAQ:DXCM) Q4 2022 Earnings Conference Call February 9, 2023 4:30 PM ET Company Participants Sean Christensen - Vice President of Finance & Investor Relations Jereme Sylvain - Executive Vice President & Chief Financial Officer Kevin Sayer - Executive Chairman, Chief Executive Officer & President Conference Call Participants Jeff Johnson - Baird Larry Beigelsen - Wells Fargo Robbie Marcus - JPMorgan Joanne Wuensch - Citibank Matthew O'Brien - Piper Sandler Marie Thibault - BTIG Travis Steed - ...